Immunity

Oncology & Cancer

Researchers identify new targets for immunotherapy in colon cancer

Colon cancer is one of the most common types of cancer. Particularly in advanced stages of disease, the treatment still largely relies on traditional chemotherapy. The new generation of cancer treatments, so-called immunotherapies, ...

Immunology

Researchers identify enzyme linked to colitis

An enzyme that usually stops bacterial growth in the large intestine stimulates inflammation in some people, resulting in ulcerative colitis—a chronic digestive disease that affects more than 750,000 Americans, according ...

Immunology

How do cells release IL-1? After three decades, now we know

Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...

Diseases, Conditions, Syndromes

Researchers make progress toward Epstein-Barr virus vaccine

A research team led by scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis ...

page 8 from 40